A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT02625389
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 132 participants
- Sponsor
- Registry
-
NCT02625389 -
CTRI/2017/05/008607
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT02625389. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-29 (actual); primary completion 2021-05-12 (actual). Results posted on 2025-10-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures
- Condition
- Congenital Hemangioma
- Condition
- Hemangioendothelioma
- Condition
- Angiosarcoma
- Condition
- Arteriovenous Malformations
- Intervention (Drug)
- Lipiodol Ultra Fluid with surgical glues
- Lead sponsor
- Guerbet
Record details
- Record id
cardio:ct-nct02625389- Content hash
9b248e8cf852c1ad6287a03f83459c02cae22b3dc0becf9272d06bebffbce105